Enzymes in Nanomedicine for Anti-tumor Therapy
Abstract Natural enzymes are biological macromolecules catalyzing reactions in living organisms and regulating biological processes. Targeted delivery of enzymes into tumor tissues for anti-tumor therapy through nanotechnology has attracted emerging interest in recent years. In this paper, we system...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Zhou, Tong [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2023 |
|---|
| Schlagwörter: |
|---|
| Anmerkung: |
© Jilin University, The Editorial Department of Chemical Research in Chinese Universities and Springer-Verlag GmbH 2023 |
|---|
| Übergeordnetes Werk: |
Enthalten in: Chemical Research in Chinese Universities - Jilin University and The Editorial Department of Chemical Research in Chinese Universities, 2012, 39(2023), 1 vom: 19. Jan., Seite 72-82 |
|---|---|
| Übergeordnetes Werk: |
volume:39 ; year:2023 ; number:1 ; day:19 ; month:01 ; pages:72-82 |
| Links: |
|---|
| DOI / URN: |
10.1007/s40242-023-2349-1 |
|---|
| Katalog-ID: |
SPR051371359 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | SPR051371359 | ||
| 003 | DE-627 | ||
| 005 | 20230510061137.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230508s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s40242-023-2349-1 |2 doi | |
| 035 | |a (DE-627)SPR051371359 | ||
| 035 | |a (SPR)s40242-023-2349-1-e | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Zhou, Tong |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Enzymes in Nanomedicine for Anti-tumor Therapy |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a © Jilin University, The Editorial Department of Chemical Research in Chinese Universities and Springer-Verlag GmbH 2023 | ||
| 520 | |a Abstract Natural enzymes are biological macromolecules catalyzing reactions in living organisms and regulating biological processes. Targeted delivery of enzymes into tumor tissues for anti-tumor therapy through nanotechnology has attracted emerging interest in recent years. In this paper, we systematically summarize the latest research progress on enzymes that used for anti-tumor therapy in nanomedicine with different action mechanisms, including anti-tumor principles, delivery modes, response modes, and synergistic therapeutic design of these enzymes. Finally, we discuss the challenges and future prospects of enzymes for anti-tumor nanomedicine. | ||
| 650 | 4 | |a Enzyme |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Nanomedicine |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Protein delivery |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Cancer therapy |7 (dpeaa)DE-He213 | |
| 700 | 1 | |a Yuan, Shuaiqi |4 aut | |
| 700 | 1 | |a Qian, Pinrong |4 aut | |
| 700 | 1 | |a Wu, Yuzhou |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Chemical Research in Chinese Universities |d Jilin University and The Editorial Department of Chemical Research in Chinese Universities, 2012 |g 39(2023), 1 vom: 19. Jan., Seite 72-82 |w (DE-627)SPR03290777X |7 nnns |
| 773 | 1 | 8 | |g volume:39 |g year:2023 |g number:1 |g day:19 |g month:01 |g pages:72-82 |
| 856 | 4 | 0 | |u https://dx.doi.org/10.1007/s40242-023-2349-1 |z lizenzpflichtig |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_SPRINGER | ||
| 951 | |a AR | ||
| 952 | |d 39 |j 2023 |e 1 |b 19 |c 01 |h 72-82 | ||
| author_variant |
t z tz s y sy p q pq y w yw |
|---|---|
| matchkey_str |
zhoutongyuanshuaiqiqianpinrongwuyuzhou:2023----:nyeinnmdcnfrniu |
| hierarchy_sort_str |
2023 |
| publishDate |
2023 |
| allfields |
10.1007/s40242-023-2349-1 doi (DE-627)SPR051371359 (SPR)s40242-023-2349-1-e DE-627 ger DE-627 rakwb eng Zhou, Tong verfasserin aut Enzymes in Nanomedicine for Anti-tumor Therapy 2023 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Jilin University, The Editorial Department of Chemical Research in Chinese Universities and Springer-Verlag GmbH 2023 Abstract Natural enzymes are biological macromolecules catalyzing reactions in living organisms and regulating biological processes. Targeted delivery of enzymes into tumor tissues for anti-tumor therapy through nanotechnology has attracted emerging interest in recent years. In this paper, we systematically summarize the latest research progress on enzymes that used for anti-tumor therapy in nanomedicine with different action mechanisms, including anti-tumor principles, delivery modes, response modes, and synergistic therapeutic design of these enzymes. Finally, we discuss the challenges and future prospects of enzymes for anti-tumor nanomedicine. Enzyme (dpeaa)DE-He213 Nanomedicine (dpeaa)DE-He213 Protein delivery (dpeaa)DE-He213 Cancer therapy (dpeaa)DE-He213 Yuan, Shuaiqi aut Qian, Pinrong aut Wu, Yuzhou aut Enthalten in Chemical Research in Chinese Universities Jilin University and The Editorial Department of Chemical Research in Chinese Universities, 2012 39(2023), 1 vom: 19. Jan., Seite 72-82 (DE-627)SPR03290777X nnns volume:39 year:2023 number:1 day:19 month:01 pages:72-82 https://dx.doi.org/10.1007/s40242-023-2349-1 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER AR 39 2023 1 19 01 72-82 |
| spelling |
10.1007/s40242-023-2349-1 doi (DE-627)SPR051371359 (SPR)s40242-023-2349-1-e DE-627 ger DE-627 rakwb eng Zhou, Tong verfasserin aut Enzymes in Nanomedicine for Anti-tumor Therapy 2023 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Jilin University, The Editorial Department of Chemical Research in Chinese Universities and Springer-Verlag GmbH 2023 Abstract Natural enzymes are biological macromolecules catalyzing reactions in living organisms and regulating biological processes. Targeted delivery of enzymes into tumor tissues for anti-tumor therapy through nanotechnology has attracted emerging interest in recent years. In this paper, we systematically summarize the latest research progress on enzymes that used for anti-tumor therapy in nanomedicine with different action mechanisms, including anti-tumor principles, delivery modes, response modes, and synergistic therapeutic design of these enzymes. Finally, we discuss the challenges and future prospects of enzymes for anti-tumor nanomedicine. Enzyme (dpeaa)DE-He213 Nanomedicine (dpeaa)DE-He213 Protein delivery (dpeaa)DE-He213 Cancer therapy (dpeaa)DE-He213 Yuan, Shuaiqi aut Qian, Pinrong aut Wu, Yuzhou aut Enthalten in Chemical Research in Chinese Universities Jilin University and The Editorial Department of Chemical Research in Chinese Universities, 2012 39(2023), 1 vom: 19. Jan., Seite 72-82 (DE-627)SPR03290777X nnns volume:39 year:2023 number:1 day:19 month:01 pages:72-82 https://dx.doi.org/10.1007/s40242-023-2349-1 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER AR 39 2023 1 19 01 72-82 |
| allfields_unstemmed |
10.1007/s40242-023-2349-1 doi (DE-627)SPR051371359 (SPR)s40242-023-2349-1-e DE-627 ger DE-627 rakwb eng Zhou, Tong verfasserin aut Enzymes in Nanomedicine for Anti-tumor Therapy 2023 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Jilin University, The Editorial Department of Chemical Research in Chinese Universities and Springer-Verlag GmbH 2023 Abstract Natural enzymes are biological macromolecules catalyzing reactions in living organisms and regulating biological processes. Targeted delivery of enzymes into tumor tissues for anti-tumor therapy through nanotechnology has attracted emerging interest in recent years. In this paper, we systematically summarize the latest research progress on enzymes that used for anti-tumor therapy in nanomedicine with different action mechanisms, including anti-tumor principles, delivery modes, response modes, and synergistic therapeutic design of these enzymes. Finally, we discuss the challenges and future prospects of enzymes for anti-tumor nanomedicine. Enzyme (dpeaa)DE-He213 Nanomedicine (dpeaa)DE-He213 Protein delivery (dpeaa)DE-He213 Cancer therapy (dpeaa)DE-He213 Yuan, Shuaiqi aut Qian, Pinrong aut Wu, Yuzhou aut Enthalten in Chemical Research in Chinese Universities Jilin University and The Editorial Department of Chemical Research in Chinese Universities, 2012 39(2023), 1 vom: 19. Jan., Seite 72-82 (DE-627)SPR03290777X nnns volume:39 year:2023 number:1 day:19 month:01 pages:72-82 https://dx.doi.org/10.1007/s40242-023-2349-1 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER AR 39 2023 1 19 01 72-82 |
| allfieldsGer |
10.1007/s40242-023-2349-1 doi (DE-627)SPR051371359 (SPR)s40242-023-2349-1-e DE-627 ger DE-627 rakwb eng Zhou, Tong verfasserin aut Enzymes in Nanomedicine for Anti-tumor Therapy 2023 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Jilin University, The Editorial Department of Chemical Research in Chinese Universities and Springer-Verlag GmbH 2023 Abstract Natural enzymes are biological macromolecules catalyzing reactions in living organisms and regulating biological processes. Targeted delivery of enzymes into tumor tissues for anti-tumor therapy through nanotechnology has attracted emerging interest in recent years. In this paper, we systematically summarize the latest research progress on enzymes that used for anti-tumor therapy in nanomedicine with different action mechanisms, including anti-tumor principles, delivery modes, response modes, and synergistic therapeutic design of these enzymes. Finally, we discuss the challenges and future prospects of enzymes for anti-tumor nanomedicine. Enzyme (dpeaa)DE-He213 Nanomedicine (dpeaa)DE-He213 Protein delivery (dpeaa)DE-He213 Cancer therapy (dpeaa)DE-He213 Yuan, Shuaiqi aut Qian, Pinrong aut Wu, Yuzhou aut Enthalten in Chemical Research in Chinese Universities Jilin University and The Editorial Department of Chemical Research in Chinese Universities, 2012 39(2023), 1 vom: 19. Jan., Seite 72-82 (DE-627)SPR03290777X nnns volume:39 year:2023 number:1 day:19 month:01 pages:72-82 https://dx.doi.org/10.1007/s40242-023-2349-1 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER AR 39 2023 1 19 01 72-82 |
| allfieldsSound |
10.1007/s40242-023-2349-1 doi (DE-627)SPR051371359 (SPR)s40242-023-2349-1-e DE-627 ger DE-627 rakwb eng Zhou, Tong verfasserin aut Enzymes in Nanomedicine for Anti-tumor Therapy 2023 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Jilin University, The Editorial Department of Chemical Research in Chinese Universities and Springer-Verlag GmbH 2023 Abstract Natural enzymes are biological macromolecules catalyzing reactions in living organisms and regulating biological processes. Targeted delivery of enzymes into tumor tissues for anti-tumor therapy through nanotechnology has attracted emerging interest in recent years. In this paper, we systematically summarize the latest research progress on enzymes that used for anti-tumor therapy in nanomedicine with different action mechanisms, including anti-tumor principles, delivery modes, response modes, and synergistic therapeutic design of these enzymes. Finally, we discuss the challenges and future prospects of enzymes for anti-tumor nanomedicine. Enzyme (dpeaa)DE-He213 Nanomedicine (dpeaa)DE-He213 Protein delivery (dpeaa)DE-He213 Cancer therapy (dpeaa)DE-He213 Yuan, Shuaiqi aut Qian, Pinrong aut Wu, Yuzhou aut Enthalten in Chemical Research in Chinese Universities Jilin University and The Editorial Department of Chemical Research in Chinese Universities, 2012 39(2023), 1 vom: 19. Jan., Seite 72-82 (DE-627)SPR03290777X nnns volume:39 year:2023 number:1 day:19 month:01 pages:72-82 https://dx.doi.org/10.1007/s40242-023-2349-1 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER AR 39 2023 1 19 01 72-82 |
| language |
English |
| source |
Enthalten in Chemical Research in Chinese Universities 39(2023), 1 vom: 19. Jan., Seite 72-82 volume:39 year:2023 number:1 day:19 month:01 pages:72-82 |
| sourceStr |
Enthalten in Chemical Research in Chinese Universities 39(2023), 1 vom: 19. Jan., Seite 72-82 volume:39 year:2023 number:1 day:19 month:01 pages:72-82 |
| format_phy_str_mv |
Article |
| institution |
findex.gbv.de |
| topic_facet |
Enzyme Nanomedicine Protein delivery Cancer therapy |
| isfreeaccess_bool |
false |
| container_title |
Chemical Research in Chinese Universities |
| authorswithroles_txt_mv |
Zhou, Tong @@aut@@ Yuan, Shuaiqi @@aut@@ Qian, Pinrong @@aut@@ Wu, Yuzhou @@aut@@ |
| publishDateDaySort_date |
2023-01-19T00:00:00Z |
| hierarchy_top_id |
SPR03290777X |
| id |
SPR051371359 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR051371359</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230510061137.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230508s2023 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/s40242-023-2349-1</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR051371359</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)s40242-023-2349-1-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Zhou, Tong</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Enzymes in Nanomedicine for Anti-tumor Therapy</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2023</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Jilin University, The Editorial Department of Chemical Research in Chinese Universities and Springer-Verlag GmbH 2023</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Abstract Natural enzymes are biological macromolecules catalyzing reactions in living organisms and regulating biological processes. Targeted delivery of enzymes into tumor tissues for anti-tumor therapy through nanotechnology has attracted emerging interest in recent years. In this paper, we systematically summarize the latest research progress on enzymes that used for anti-tumor therapy in nanomedicine with different action mechanisms, including anti-tumor principles, delivery modes, response modes, and synergistic therapeutic design of these enzymes. Finally, we discuss the challenges and future prospects of enzymes for anti-tumor nanomedicine.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Enzyme</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Nanomedicine</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Protein delivery</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cancer therapy</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Yuan, Shuaiqi</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Qian, Pinrong</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wu, Yuzhou</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Chemical Research in Chinese Universities</subfield><subfield code="d">Jilin University and The Editorial Department of Chemical Research in Chinese Universities, 2012</subfield><subfield code="g">39(2023), 1 vom: 19. Jan., Seite 72-82</subfield><subfield code="w">(DE-627)SPR03290777X</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:39</subfield><subfield code="g">year:2023</subfield><subfield code="g">number:1</subfield><subfield code="g">day:19</subfield><subfield code="g">month:01</subfield><subfield code="g">pages:72-82</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.1007/s40242-023-2349-1</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">39</subfield><subfield code="j">2023</subfield><subfield code="e">1</subfield><subfield code="b">19</subfield><subfield code="c">01</subfield><subfield code="h">72-82</subfield></datafield></record></collection>
|
| author |
Zhou, Tong |
| spellingShingle |
Zhou, Tong misc Enzyme misc Nanomedicine misc Protein delivery misc Cancer therapy Enzymes in Nanomedicine for Anti-tumor Therapy |
| authorStr |
Zhou, Tong |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)SPR03290777X |
| format |
electronic Article |
| delete_txt_mv |
keep |
| author_role |
aut aut aut aut |
| collection |
springer |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
Enzymes in Nanomedicine for Anti-tumor Therapy Enzyme (dpeaa)DE-He213 Nanomedicine (dpeaa)DE-He213 Protein delivery (dpeaa)DE-He213 Cancer therapy (dpeaa)DE-He213 |
| topic |
misc Enzyme misc Nanomedicine misc Protein delivery misc Cancer therapy |
| topic_unstemmed |
misc Enzyme misc Nanomedicine misc Protein delivery misc Cancer therapy |
| topic_browse |
misc Enzyme misc Nanomedicine misc Protein delivery misc Cancer therapy |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
cr |
| hierarchy_parent_title |
Chemical Research in Chinese Universities |
| hierarchy_parent_id |
SPR03290777X |
| hierarchy_top_title |
Chemical Research in Chinese Universities |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)SPR03290777X |
| title |
Enzymes in Nanomedicine for Anti-tumor Therapy |
| ctrlnum |
(DE-627)SPR051371359 (SPR)s40242-023-2349-1-e |
| title_full |
Enzymes in Nanomedicine for Anti-tumor Therapy |
| author_sort |
Zhou, Tong |
| journal |
Chemical Research in Chinese Universities |
| journalStr |
Chemical Research in Chinese Universities |
| lang_code |
eng |
| isOA_bool |
false |
| recordtype |
marc |
| publishDateSort |
2023 |
| contenttype_str_mv |
txt |
| container_start_page |
72 |
| author_browse |
Zhou, Tong Yuan, Shuaiqi Qian, Pinrong Wu, Yuzhou |
| container_volume |
39 |
| format_se |
Elektronische Aufsätze |
| author-letter |
Zhou, Tong |
| doi_str_mv |
10.1007/s40242-023-2349-1 |
| title_sort |
enzymes in nanomedicine for anti-tumor therapy |
| title_auth |
Enzymes in Nanomedicine for Anti-tumor Therapy |
| abstract |
Abstract Natural enzymes are biological macromolecules catalyzing reactions in living organisms and regulating biological processes. Targeted delivery of enzymes into tumor tissues for anti-tumor therapy through nanotechnology has attracted emerging interest in recent years. In this paper, we systematically summarize the latest research progress on enzymes that used for anti-tumor therapy in nanomedicine with different action mechanisms, including anti-tumor principles, delivery modes, response modes, and synergistic therapeutic design of these enzymes. Finally, we discuss the challenges and future prospects of enzymes for anti-tumor nanomedicine. © Jilin University, The Editorial Department of Chemical Research in Chinese Universities and Springer-Verlag GmbH 2023 |
| abstractGer |
Abstract Natural enzymes are biological macromolecules catalyzing reactions in living organisms and regulating biological processes. Targeted delivery of enzymes into tumor tissues for anti-tumor therapy through nanotechnology has attracted emerging interest in recent years. In this paper, we systematically summarize the latest research progress on enzymes that used for anti-tumor therapy in nanomedicine with different action mechanisms, including anti-tumor principles, delivery modes, response modes, and synergistic therapeutic design of these enzymes. Finally, we discuss the challenges and future prospects of enzymes for anti-tumor nanomedicine. © Jilin University, The Editorial Department of Chemical Research in Chinese Universities and Springer-Verlag GmbH 2023 |
| abstract_unstemmed |
Abstract Natural enzymes are biological macromolecules catalyzing reactions in living organisms and regulating biological processes. Targeted delivery of enzymes into tumor tissues for anti-tumor therapy through nanotechnology has attracted emerging interest in recent years. In this paper, we systematically summarize the latest research progress on enzymes that used for anti-tumor therapy in nanomedicine with different action mechanisms, including anti-tumor principles, delivery modes, response modes, and synergistic therapeutic design of these enzymes. Finally, we discuss the challenges and future prospects of enzymes for anti-tumor nanomedicine. © Jilin University, The Editorial Department of Chemical Research in Chinese Universities and Springer-Verlag GmbH 2023 |
| collection_details |
GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER |
| container_issue |
1 |
| title_short |
Enzymes in Nanomedicine for Anti-tumor Therapy |
| url |
https://dx.doi.org/10.1007/s40242-023-2349-1 |
| remote_bool |
true |
| author2 |
Yuan, Shuaiqi Qian, Pinrong Wu, Yuzhou |
| author2Str |
Yuan, Shuaiqi Qian, Pinrong Wu, Yuzhou |
| ppnlink |
SPR03290777X |
| mediatype_str_mv |
c |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| doi_str |
10.1007/s40242-023-2349-1 |
| up_date |
2024-07-03T21:24:53.379Z |
| _version_ |
1803594648393875456 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR051371359</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230510061137.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230508s2023 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/s40242-023-2349-1</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR051371359</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)s40242-023-2349-1-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Zhou, Tong</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Enzymes in Nanomedicine for Anti-tumor Therapy</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2023</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Jilin University, The Editorial Department of Chemical Research in Chinese Universities and Springer-Verlag GmbH 2023</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Abstract Natural enzymes are biological macromolecules catalyzing reactions in living organisms and regulating biological processes. Targeted delivery of enzymes into tumor tissues for anti-tumor therapy through nanotechnology has attracted emerging interest in recent years. In this paper, we systematically summarize the latest research progress on enzymes that used for anti-tumor therapy in nanomedicine with different action mechanisms, including anti-tumor principles, delivery modes, response modes, and synergistic therapeutic design of these enzymes. Finally, we discuss the challenges and future prospects of enzymes for anti-tumor nanomedicine.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Enzyme</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Nanomedicine</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Protein delivery</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cancer therapy</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Yuan, Shuaiqi</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Qian, Pinrong</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wu, Yuzhou</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Chemical Research in Chinese Universities</subfield><subfield code="d">Jilin University and The Editorial Department of Chemical Research in Chinese Universities, 2012</subfield><subfield code="g">39(2023), 1 vom: 19. Jan., Seite 72-82</subfield><subfield code="w">(DE-627)SPR03290777X</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:39</subfield><subfield code="g">year:2023</subfield><subfield code="g">number:1</subfield><subfield code="g">day:19</subfield><subfield code="g">month:01</subfield><subfield code="g">pages:72-82</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.1007/s40242-023-2349-1</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">39</subfield><subfield code="j">2023</subfield><subfield code="e">1</subfield><subfield code="b">19</subfield><subfield code="c">01</subfield><subfield code="h">72-82</subfield></datafield></record></collection>
|
| score |
7.4009285 |